Plasma cyclic AMP in manic-depressive illness.

Area of Science:

• Biochemistry
• Psychiatry
• Neuroscience

Background:

• Manic-depressive illness, also known as bipolar disorder, is a mood disorder characterized by alternating periods of mania and depression.
• Previous research has suggested a potential disturbance in cyclic AMP (cAMP) signaling pathways in the pathophysiology of bipolar disorder.

Purpose of the Study:

• To investigate the role of cyclic AMP (cAMP) in manic-depressive illness by measuring plasma cAMP levels.
• To determine if plasma cAMP concentrations differ between depressed, manic, and euthymic phases of the illness compared to healthy controls.

Main Methods:

• Plasma samples were collected from drug-free patients diagnosed with depression or mania, euthymic bipolar patients, and healthy controls.
• Cyclic AMP (cAMP) concentrations were quantified using a validated protein-binding assay.
• The effects of neuroleptics, tricyclics, and lithium on plasma cAMP levels were examined.

Main Results:

• Depressed patients exhibited significantly lower plasma cAMP levels, while manic patients showed significantly higher levels compared to controls.
• Euthymic bipolar patients had normal plasma cAMP concentrations.
• Neuroleptics reduced cAMP in mania, tricyclics elevated it in depression, and lithium normalized cAMP levels in both phases.

Conclusions:

• Manic-depressive illness is associated with a distinct disturbance in the cyclic AMP (cAMP) system.
• Plasma cAMP levels serve as a reliable biomarker for assessing the state of cAMP in psychiatric disorders.
• Measuring plasma cAMP offers a valuable diagnostic and monitoring tool for bipolar disorder.